Scleroderma

Top Story

Proposed '15% rule' outlines common organ complications in scleroderma

Proposed '15% rule' outlines common organ complications in scleroderma
February 19, 2020
FDA News

FDA grants orphan drug status to IV immunoglobulin treatment for systemic sclerosis

February 11, 2020
The FDA has granted orphan drug designation to an investigational intravenous immunoglobulin therapy for the treatment of systemic sclerosis, according to a press…
In the Journals

Systemic sclerosis linked to higher risk for gastrointestinal bleeding

January 21, 2020
Patients with systemic sclerosis are at a significantly higher risk for gastrointestinal bleeding compared with those without the disease, according to data published in…
In the Journals

SSc-related digital ulcers linked to worse disease burden, worse QoL, excess costs

January 16, 2020
Patients with digital ulcers related to systemic sclerosis experience worse disease burden, worse quality of life and an excess annual cost of AUD $12,474 per patient…
More Headlines »